ELECTIVE OPTION OFFERS APPROVED
2,686
As of May 15, 2026
The DOJ and Navy launched the Elective Option in September 2023 with a two-tier grid: Tier 1 diseases (including bladder and kidney cancer, NHL, and leukemia) at $150K/$300K/$450K by exposure duration; Tier 2 (including Parkinson's and kidney disease) at $100K/$250K/$400K.
Uptake has been slow relative to the claim pool: roughly 2,686 offers approved against more than 408,000 administrative claims by mid-2026. Whether to accept a fixed offer versus litigate is exactly the kind of decision your firm exists to advise on.
Sources & attribution